Trials / Completed
CompletedNCT03604146
Quality Control for Chronic Obstructive Pulmonary Disease
Establishment of Quality Control Index System and Strategy for Chronic Obstructive Pulmonary Disease in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,600 (actual)
- Sponsor
- Guangzhou Institute of Respiratory Disease · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This is a 1 year longitudinal study to establish a related index system for chronic obstructive pulmonary disease(COPD) quality control.Clinical and economic data of COPD patients will be collected and analyzed.
Detailed description
Sixteen hospitals in Guangdong Province were randomly divided into control group and intervention group.Doctors and nurses of intervention group were trained treat chronic obstructive pulmonary disease according to the GOLD(Global InitiaTive of Chronic Obstructive Lung Disease) guidelines，while those in the control group will not receive any training from research team. Hospital patient cohort and outpatient cohort will be setted. Subjects were interviewed and received pulmonary function tests.All patients will be followed and events of acute exacerbation will be recorded.Factors that influence patient prognosis and economic-health benefits will be analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Medical quality control intervention strategy | Training and education for diagnosis, treatment and management of COPD for doctors and nurses; Regular inspection and supervision of medical quality |
Timeline
- Start date
- 2018-03-20
- Primary completion
- 2020-06-30
- Completion
- 2020-12-30
- First posted
- 2018-07-27
- Last updated
- 2021-02-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03604146. Inclusion in this directory is not an endorsement.